Dr. Reddy’s gains on inking agreement to acquire product portfolio from Teva in US for $350 million

13 Jun 2016 Evaluate

Dr. Reddy’s Laboratories is currently trading at Rs. 3081.00, up by 16.40 points or 0.54% from its previous closing of Rs. 3064.60 on the BSE.

The scrip opened at Rs. 3095.00 and has touched a high and low of Rs. 3095.90 and Rs. 3073.00 respectively. So far 2,782 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750.00 on 21-Jan-2016.

Last one week high and low of the scrip stood at Rs. 3182.80 and Rs. 3048.05 respectively. The current market cap of the company is Rs. 52,574.00 crore.

The promoters holding in the company stood at 25.58% while Institutions and Non-Institutions held 42.02% and 32.40% respectively.

Dr. Reddy’s Laboratories has entered into a definitive agreement with Teva Pharmaceutical Industries (Teva) and an affiliate of Allergan plc to acquire a portfolio of eight Abbreviated New Drug Applications (ANDAs) in the US for $350 million in cash at closing. The acquired portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan’s generics business. The acquisition of these ANDAs is also contingent on the closing of the Teva/Allergan generics transaction and approval by the US Federal Trade Commission of Dr. Reddy’s as a buyer.

The portfolio being acquired is a mix of filed ANDAs pending approval and an approved ANDA, and comprised of complex generic products across diverse dosage forms. According to IMS Health, the combined sales of the branded versions of the products in the US are approximately $3.5 billion MAT for the most recent twelve months ending in April 2016.

Dr. Reddy’s Laboratories is acquiring the portfolio on a cash-free, debt-free basis and expects to finance the transaction using a combination of cash on hand and available borrowings under existing credit facilities.


Dr. Reddys Lab Share Price

1175.55 -10.90 (-0.92%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×